HomeSearchnpj Precision Oncology

npj Precision Oncology

Nature Portfolio · United Kingdom · Est. 1972

eISSN2397-768X
SJR Q1WOS SCIEScopus / SJRDOAJOpen Access
100
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
WoS flagship (SCIE/SSCI/AHCI)78
✓ Corroboration (4 more)+22
Total100
Level data: Norwegian Register (HK-dir), NLOD 2.0. · Third-party records · how this is calculated · Report an error →
⚡ Speed vs Prestige
How does this journal balance review speed with impact level?
207
days submission → published
measured · last 19 articles · accept 195d
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile · Web of Science (JCR)

✓ Indexed in the Web of Science Core Collection (SCIE) — Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page ↗

The Impact Factor & JCR quartile are licensed by Clarivate — we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
3.616
H-Indexi
75
CiteScore
View ↗
Scopus metric · on the journal’s page
SNIPi
1.541
Total Worksi
1,388
Total Citationsi
28,288
2yr Mean Citednessi
7.28
Open Impact Factor alternative

Aims & Scope

npj Precision Oncology considers research covering all aspects of basic science, translational, and clinical research in the field of precision oncology. The journal broadly defines precision oncology as cancer diagnosis, prognosis, prevention, and treatment tailored specifically to the individual patient based on the genetic and/or molecular profile of the patient. We welcome innovative, well-conducted, and deep studies. The journal covers a broad range of topics including but not limited to: Targeted therapy and precision medicine clinical trials and therapeutic strategies Biomarker studies that include both biological and external validation using an independent cohort Immunotherapies, immune checkpoint inhibitors, adoptive cell therapies, cancer vaccines, and immunomodulatory agents for personalized cancer treatment Applications of liquid biopsy techniques, including circulating tumor DNA, circulating tumor cells, and exosomes, for non-invasive cancer detection, monitoring, and treatment response assessment Tumor heterogeneity, clonal evolution, and tumor microenvironment dynamics in cancer progression, metastasis, and therapy resistance Genomic profiling and molecular characterization of cancer Drug resistance mechanisms and therapeutic strategies Clinical applications of predictive modeling, artificial intelligence, and computational oncology, including studies on large language models for research applications or clinical applications in oncology; and studies on deep learning-based data analysis in oncology with external validation and clear clinical potential Pharmacogenomics and drug metabolism, including secondary analyses of clinical trial datasets Microbiome studies only with clear evidence of relevance to a precision oncology treatment The journal offers more choice to Nature Portfolio authors who are seeking a fully open-access and more inclusive platform for publishing their work. The journal is led by oncology experts who collaborate to cultivate high-quality research. As part of the npj Series , this journal focuses on fostering global partnerships with the research community and other Springer Nature journals.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1972
StatusActive (last: 2026)
Total Publications1,388
Publisher OrgNature Portfolio
OA Since2016
Visit Journal Website

Submission Info

APC Cost€3,490
Peer ReviewAnonymous peer review
Review Time
Acceptance Rate
OA LicenseCC BY, CC BY-NC-ND
OA Rate

Ethics & Quality

COPE Member✗ No
OASPA Member✗ No
Not on Predatory Lists✓ Yes
Plagiarism Detection✓ Yes

Think.Check.Submit Compliance

10/12 · 83%
Do you know the journal / publisher?
Nature Portfolio
Does the journal have a website?
✓ Linked
Is the ISSN verified?
2397-768X
Indexed in a trusted database?
WoS, Scopus, DOAJ, PubMed
Peer review process documented?
Anonymous peer review
Follows ethical publishing standards (COPE)?
N/A
APC fees clearly disclosed?
€3,490
Not on predatory/blacklists?
✓ Clean
Long-term digital preservation?
N/A
Plagiarism detection in place?
Yes
Listed in DOAJ (verified OA)?
DOAJ verified
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Cancer ResearchQ1
OncologyQ1

Subject Classification

Web of Science Categories

Oncology

Research Topics (OpenAlex)

Cancer Genomics and DiagnosticsCancer Immunotherapy and BiomarkersRadiomics and Machine Learning in Medical ImagingLung Cancer Treatments and MutationsFerroptosis and cancer prognosisCancer Cells and MetastasisAI in cancer detectionSingle-cell and spatial transcriptomicsRNA modifications and cancerGlioma Diagnosis and Treatment

Frequently asked questions about npj Precision Oncology

Is npj Precision Oncology a predatory journal?

PubScope has no integrity flags on record for npj Precision Oncology: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 100/100. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of npj Precision Oncology?

npj Precision Oncology is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal — including Arts & Humanities and Emerging Sources titles — receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 7.28.

Is npj Precision Oncology indexed in Scopus and Web of Science?

npj Precision Oncology is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of npj Precision Oncology?

npj Precision Oncology considers research covering all aspects of basic science, translational, and clinical research in the field of precision oncology. The journal broadly defines precision oncology as cancer diagnosis, prognosis, prevention, and treatment tailored specifically to the individual patient based on the genetic and/or molecular profile of the patient. We welcome innovative, well-conducted, and deep studies. The journal covers a broad range of topics including but not limited to: Targeted therapy and precision medicine clinical trials and therapeutic strategies Biomarker studies

How much does it cost to publish in npj Precision Oncology?

npj Precision Oncology charges an article processing charge (APC) of about €3,490 for open-access publication.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref